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Context. Previous research suggests that patients receiving palliative care may
simultaneously experience poorly managed pain and post-traumatic stress
disorder (PTSD)-related symptoms as a result of their deteriorating health.
Objectives. To: 1) examine predictors of PTSD-related symptoms in patients
requiring palliative care; 2) assess whether anxiety, depression, pain
catastrophizing, and pain anxiety mediate the relationship between pain
interference and PTSD-related symptoms; and 3) evaluate the impact of these
variables on pain interference and PTSD-related symptoms.
Methods. One hundred patients receiving palliative care at one of two palliative
care sites in London, ON, Canada, completed the PTSD ChecklistdCivilian
version (PCL-C), the Hospital Anxiety and Depression Scale (HADS), the Pain
Catastrophizing Scale (PCS), the Brief Pain Inventory-Short Form (BPI-SF), and
the Pain Anxiety Symptoms Scale-20 (PASS-20). Hierarchical multiple regressions
were used to examine HADS-Anxiety, HADS-Depression, PCS and PASS-20 scores
as predictors of PCL-C scores; and mediation analyses were used to test the effect
of HADS-Anxiety, HADS-Depression, PCS, and PASS-20 on the relationship
between BPI-SF interference and PCL-C. Mediators that significantly affected this
relationship in the individual mediator models were entered into a multiple
mediator model.
Results. Only pain anxiety and pain catastrophizing emerged as significant
mediators of the relationship between pain interference and PTSD-related
symptoms. After being entered in a multiple mediator model, pain anxiety
emerged as the strongest mediator.
Conclusion. The findings of the present study reveal that pain and
PTSD-related symptoms are important concerns in palliative care, and that pain 
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Despite the advances in the management of
physical symptoms and psychological issues in
patients requiring palliative care, pain and psy-
chological distress remain significant concerns.
Pain and its related suffering, including depres-
sion, feelings of isolation, and anxiety, are often
accepted as ‘‘normal’’ experiences along the tra-
jectory of dying1 and these conditions may be
somewhat overlooked as a result of this per-
ception. Although palliative care aims to
control pain and distress, and to provide com-
fort to patients as their health progressively
deteriorates,2e5 it is a complex field, and care is
best providedby amultidisciplinary teamandap-
proach.6,7 To effectively meet the needs of this
population, the issue of painmust be addressed.
Previous research suggests that pain, con-
ceptualized by the International Association
for the Study of Pain as a product of noxious
stimulation that causes an emotionally evoca-
tive reaction,8 is prevalent among patients
with cancer9e15 and those requiring palliative
care services.9,14,16e18 Pain in the oncology
and palliative care settings tends to be under-
diagnosed and poorly treated.9,11,13,19,20 Inade-
quate pain assessment may lead to insufficient
analgesia, which may subsequently lead to in-
creased psychological and physical distress.12
Emerging research has focused on ex-
ploring the implications of psychological dis-
tress, including post-traumatic stress disorder
(PTSD)-related symptoms, in the oncology
and palliative domains of care. PTSD-related
symptoms, such as avoidance and emotional
numbing, a feeling of detachment from
others, and irritability and anger,21 have been
associated with cancer-related symptoms, diag-
nosis, and treatment,22 and many researchers
support the validity of PTSD-related symptoms
in patients with cancer and those requiring
palliative care services.23e28 Despite this, the
nature of the relationship between psychologi-
cal distress and pain among palliative care pa-
tients has not been widely studied to date.
However, outside of the realm of palliative
care, pain researchers have aimed to better
understand the relationship between PTSD-related symptoms and pain. The mutual main-
tenance model of pain and PTSD, which
suggests that pain and PTSD are mutually main-
tained by seven possible mechanisms, may be an
exceptionally usefulmodel in exploring the rela-
tionship between pain and PTSD-related symp-
toms in patients requiring palliative care. These
mechanisms are: 1) attention and reasoning
biases, 2) anxiety sensitivity, 3) reminders of the
trauma, 4) avoidance, 5) depression and re-
duced activity levels, 6) anxiety and pain percep-
tion, and 7) cognitive demand from symptoms
limiting the use of adaptive strategies.29 As
such, the objectives of the present study are to:
1)examinecorrelatesofPTSD-related symptoms
in patients requiring palliative care; 2) assess
whether anxiety, depression, pain catastrophiz-
ing, and pain anxiety mediate the relationship
between pain interference and PTSD-related
symptoms; and 3) evaluate the relationship of
these variables on pain interference and PTSD-
related symptoms in amultiplemediator model.Methods
Ethics approval for this study was obtained
from the Human Participants Review Commit-
tee at York University and the University of
Western Ontario Health Sciences Research
Ethics Board.
Participant Data
A total of 168 participants older than 18 years
with a cancer diagnosis were approached for re-
cruitment from two primary sites: the London
Regional Cancer Program (Palliative Medicine
Outpatient Clinic and Lung Cancer Clinic) and
the London Health Sciences CentredVictoria
Hospital campus (Palliative CareUnit andPallia-
tiveMedicineConsultationService).Participants
were excluded if they: 1) could not read or un-
derstand English; 2) were deemed not appropri-
ate (i.e., had a visual or hearing impairment,
could not speak because of amedical procedure,
were nonpalliative medicine patients attending
an appointment at the Palliative Medicine Out-
patient Clinic or occupying an inpatient bed in
the palliative care unit), or deemed too ill to
participate by palliative medicine physicians and
nurses; or 3) were confused, delirious, or did not
score above the cutoff of 24 of 30 on the Mini-
Mental State Examination (MMSE).
Measures
Participants completed the following mea-
sures, which are briefly described in the follow-
ing sections.
Brief Pain Inventory-Short Form.30 The Brief
Pain Inventory-Short Form (BPI-SF) measures
the past 24 hour pain intensity and pain inter-
ference, which can be described as the disrup-
tion of activity or functioning because of pain
or fear of pain. Total pain intensity scores range
from zero to 10, and pain interference scores
range from zero to 70, with higher scores indi-
cating greater pain intensity and interference,
respectively. The BPI-SF has demonstrated ade-
quate reliability, sensitivity, and validity in previ-
ously conducted multicenter studies.31 In the
present study, Cronbach’s alpha for pain inter-
ference was 0.87. Internal consistency could
not be calculated for pain intensity because
a single numerical rating scale of current pain
intensity was used for this variable.
Hospital Anxiety and Depression Scale.32 The
Hospital Anxiety and Depression Scale (HADS)
is a 14-item self-report questionnaire that mea-
sures the severity of anxiety and depressive symp-
toms. Depression and anxiety subscale scores
range fromzero to 21, withhigher scores indicat-
ing greater symptom severity. Both the HADS-A
(anxiety subscale) and the HADS-D (depression
subscale) have been demonstrated to have good
sensitivity and specificity.33 In the present study,
Cronbach’s alpha for the HADS-A and HADS-D
subscales were 0.82 and 0.80, respectively.
Mini-Mental State Examination.34 TheMMSE is
a brief quantitative measure of cognitive status
and was used in this study to determine whether
a potential recruit was cognitively suitable for
participation in the study. A cutoff score of 24
out of 30 is recommendedwhen screeningmed-
ical populations for impairment.34High levels of
internal consistency35 and test-retest reliability34
have been reported in mixed medical samples,
and the measure demonstrates moderate-to-
high levels of sensitivity and specificity in
a variety of clinical and control samples.36Pain Anxiety Symptoms Scale-20.37 The Pain
Anxiety Symptoms Scale-20 (PASS-20) is a 20-
item self-report questionnaire that assesses
four components of pain anxiety: cognitive anx-
iety, escape/avoidance behaviors, fear of pain,
and physiological symptoms of anxiety. A total
score is generated by summing all responses
and ranges from zero to 100, with higher scores
indicating higher pain anxiety. The PASS-20 has
demonstrated good reliability and validity in in-
dividuals with pain attending physiotherapy
clinics.38 In the present study, Cronbach’s alpha
for the total score and fear of pain, cognitive
anxiety, escape/avoidance behaviors, and
physiological symptoms of anxiety subscale
scores were 0.93, 0.83, 0.87, 0.78, and 0.72,
respectively.
Pain Catastrophizing Scale.39 The Pain Cata-
strophizing Scale (PCS) measures ‘‘an exagger-
ated negative ‘mental set’ brought to bear
during actual or anticipated pain experi-
ence.’’39, p. 53 A total score ranging from zero
to 52 is tabulated, with higher scores indicating
greater pain catastrophizing. Scores for three
subscales (rumination,magnification, andhelp-
lessness) also are generated. The PCS shows
high internal consistency and validity in adult
community and clinical pain samples.40 In the
present study, Cronbach’s alpha for the total
score and rumination, magnification, and help-
lessness subscale scores were 0.93, 0.89, 0.74,
and 0.85, respectively.
PTSD ChecklistdCivilian Version.41 The PTSD
ChecklistdCivilian version (PCL-C) is a 17-item
self-administered questionnaire that assesses se-
verity of PTSD symptoms. Scores range from 17
to 85, and cutoff scores that reliably predict
a diagnosis of PTSD range between 4441 and
50.42 A validation study of university students
revealed high levels of internal consistency, test-
retest reliability, and convergent and discrimi-
nant validity.43 In the present study, Cronbach’s
alpha for the total score and re-experiencing,
avoidance,numbing,andhyperarousal subscales
were 0.89, 0.74, 0.80, 0.78, and 0.74, respectively.
Scores from two previously completed ques-
tionnairesdthe Edmonton Symptom Assess-
ment System (ESAS)44 and the Palliative
Performance Scale45dwere extracted frompar-
ticipants’ medical charts. The ESAS is a self-
report questionnaire that assesses the presence
and severity of nine symptoms commonly expe-
rienced by patients requiring palliative care:
pain, fatigue, nausea, depression, anxiety,
drowsiness, appetite, sense of well-being, and
shortness of breath.44,46 Scores for each of the
nine items range from zero to 10, with higher
scores indicating greater symptom severity. In
the present study, Cronbach’s alpha for the
ESAS severity score was 0.88. The Palliative Per-
formance Scale is a clinician-rated measure of
functional performance and allows for themea-
surement of progressive decline in patients
requiring palliative care. Scores range from
zero to 100, in 10% increments, where zero
indicates death and 100 is indicative of a fully
functioning and ambulatory patient.45
Recruitment and Data Collection
A total of 168 patients were identified during
the recruitment period from May 30 to Decem-
ber 19, 2008. Of these, 24 declined participa-
tion; a further 38 were missed by the study
investigator (investigator not available, patient
not available, or patient died before being
reached by investigator). Three more patients
did not meet the MMSE cutoff criterion, two
withdrew consent partway through completing
the questionnaires, and one patient was identi-
fied as nonpalliative after completion of the
study questionnaires, leaving a sample size of
100 (response rate of 59.5%).
Participants completed the aforementioned
questionnaires after providing written informed
consent.A total of 89participants completed the
questionnaires in the presence of the study
investigator (M. L. R.), and the remaining
11 participants completed the questionnaires
independently. Demographic and disease-
related data, including age, sex, marital status,Fig. 1. Path diagram of simple mediation models. Path a is
mediator variable. Path b is the path between the mediator
direct effect between the independent variable and depend
sion Scale; PCS¼ Pain Catastrophizing Scale; PASS-20¼ Pa
Inventory-Short Form; PCL-C¼ Post-Traumatic Stress Disordcancer diagnosis, stage of cancer at date of diag-
nosis, and current state of diagnosis, were ex-
tracted directly from participants’ medical
records. Questionnaire data were manually en-
tered into the Statistical Package for the Social
Sciences, version 15.0 (SPSS Inc., Chicago, IL),
and questionnaire-scoring syntax statements
were created to compute summary scores for
the BPI-SF, ESAS, HADS, PASS-20, PCS, and
PCL-C.
Statistical Analyses
All data were screened for missing data, uni-
variate and multivariate outliers, and skewed
distribution as per procedures described by Ta-
bachnick and Fidell47 and Field.48 Missing data,
which represented 4% of all data, appeared to
be random and, therefore, was not imputed,
as per Tabachnick and Fidell;47 rather, total
scores were calculated by summing the items
without creating a weighted total based on the
missing items. Visual inspection of frequency
distributions ensured that all scale summary
scores fell within the expected ranges.
Hierarchicalmultiple regressionswereused to
examine HADS-A, HADS-D, PCS, and PASS-20
scores as statistical predictors of PCL-C scores,
after controlling for BPI-SF intensity, BPI-SF
interference, and ESAS.
Simplemediation analyses (Fig. 1) were tested
using Baron and Kenny’s49 linear multiple re-
gression model. These analyses were used to
test the effect of four independent variables on
the relationship between BPI-SF pain interfer-
ence and PTSD-related symptoms (PCL-C
scores): HADS-A (Model 1), HADS-D (Model
2), pain catastrophizing (PCS scores; Model 3),
and pain anxiety (PASS-20 scores; Model 4). For
each unique model, four steps were taken. Inthe path between the independent variable and the
variable and the dependent variable. Path c’ is the
ent variable. HADS¼Hospital Anxiety and Depres-
in Anxiety Symptoms Scale-20; BPI-SF¼ Brief Pain
er ChecklistdCivilian version.
Step 1 of each model, BPI-SF pain interference
was assessed as a predictor of PCL-C scores. In
Step 2, BPI-SF pain interference was assessed as
a predictor of the model’s independent variable
(i.e., HADS-A in Model 1). In Step 3, controlling
for BPI-SF pain interference, the independent
variable (i.e., HADS-A in Model 1), was assessed
as a predictor of PCL-C scores. In the final step,
controlling for the independent variable (i.e.,
HADS-A inModel 1), BPI-SF interference was as-
sessed as a predictor of PCL-C scores. Bootstrap-
ping significance tests were applied to each
model, using n¼ 5000 bootstrap resamples,50
to assess the independent variable as a mediator
of the relationship between pain interference
and PTSD-related symptoms. A Bonferroni
correction was applied to the Type I error rate
to control the overall Type I error when
multiple tests of significance are conducted.
For all analyses, bootstrapped confidence
intervals (CIs) were used to evaluate the
statistical significance of the mediated models.
Lastly, a separate multiple mediator model,
which followed the same approach as the four
simple mediation analyses, was used to assess
the effect of multiple mediator variables on
the relationship between BPI-SF interference
and PCL-C scores. Standardized regression co-
efficients were generated for each of themedia-
tors, and bootstrapping was again used to
construct CIs around the regression coefficients
in themediation analysis to test the significance
of indirect effects.51 Mediators for the multiple
mediator model were selected based on the
results of the individual mediator models. If
a mediator was found to significantly affect the
relationship between the independent andFig. 2. Path diagram of final multiple mediation model. Pat
variable and the mediator variables. Paths b1 and b2 are the p
dent variable. Path c’ is the direct effect between the indepe
Catastrophizing Scale; BPI-SF¼ Brief Pain Inventory-Sho
ChecklistdCivilian version; PASS-20¼ Pain Anxiety Symptomdependent variables in its own unique indivi-
dual mediator model, it was entered into the
multiple mediator model (Fig. 2).Results
Table 1 presents a summary of demographic-,
cancer-, and pain-related information. Twenty-
five percent (n¼ 25) reported clinically sig-
nificant symptoms of anxiety, and 43%
(n¼ 43) reported clinically significant symp-
toms of depression, as measured by the
HADS-A and HADS-D subscales, respectively.
Seven percent (n¼ 7) of participants met or
exceeded the cutoff score of 4441 for clinically
significant PTSD-related symptoms. The mean
PCL-C score was 25.88 10.40.
Hierarchical Regression Analysis
Thehierarchical regression analysis (Table 2)
showed that pain intensity and pain interfer-
ence significantly predicted PCL-C scores in
Step 1 and accounted for 22% of the variance
in PCL-C scores. The addition of symptom dis-
tress in Step 2 was not a significant predictor
of PCL-C scores. After controlling for all vari-
ables in the model, pain anxiety scores ac-
counted for a significant proportion of the
variance in PCL-C scores and was the only vari-
able that significantly predicted PCL-C scores.
Simple Mediation Analyses
The results of the mediation analyses are
presented step by step in Table 3. It is worth-
while to note that neither anxiety nor depres-
sion emerged as a significant mediator ofhs a1 and a2 are the paths between the independent
aths between the mediator variables and the depen-
ndent variable and dependent variable. PCS¼ Pain
rt Form; PCL-C¼ Post-Traumatic Stress Disorder
s Scale-20.
Table 1
Demographic- and Disease-Related
Characteristics of the Sample
Parameters n (%)
Age (yrs)a
Mean (SD) 63.4 (13.76)
Minimum, maximum 19, 87
Sexa
Male 37 (37)
Female 63 (63)
Age groups (yrs)a
19e49 17 (17)
50e59 18 (18)
60e69 22 (22)
70e74 18 (18)
75e87 25 (25)
Marital statusa
Single 12 (12)
Married 55 (55)
Common law 4 (4)
Divorced 13 (13)
Separated 5 (5)
Widowed 11 (11)
Patient typea
Inpatient 37 (37)
Outpatient 63 (63)
Cancer typea
Breast 8 (8)
Genitourinary 11 (11)
Colon 9 (9)
Other gastrointestinal 22 (22)
Gynecological 20 (20)
Lung 13 (13)
Primary unknown 8 (8)
Other 9 (9)
Metastases at diagnosisb
Yes 51 (51)
No 34 (34)
Pain categorya
None 19 (19)
Mild 56 (56)
Moderate 17 (17)
Severe 8 (8)
aN¼ 100.
bN¼ 85.BPI-SF interference and PCL-C scores. How-
ever, pain catastrophizing emerged as a sig-
nificant mediator of BPI-SF pain interference
and PCL-C scores (63% of total effect medi-
ated by pain catastrophizing), as did pain anx-
iety (79% of total effect mediated by pain
anxiety).
Multiple Mediation Analysis
Pain catastrophizing and pain anxiety were
entered into the multiple mediation model
(Table 4); because anxiety and depression
were not statistically significant mediators of
the relationship between BPI-SF interference
and PCL-C scores, they were not entered into
the model. In Step 1 of the multiplemediation model, BPI-SF interference signifi-
cantly predicted PCL-C scores and in Step 2,
BPI-SF interference significantly predicted
both pain catastrophizing and pain anxiety.
In Step 3, controlling for BPI-SF interference
and pain anxiety, pain catastrophizing did
not significantly predict PCL-C scores, whereas
controlling for BPI-SF interference and pain
catastrophizing, pain anxiety significantly pre-
dicted PCL-C scores. In this step, pain cata-
strophizing did not mediate the relationship
between BPI-SF interference and PCL-C scores
above and beyond pain anxiety. In Step 4 of
the multiple mediation model, controlling
for pain catastrophizing and pain anxiety,
BPI-SF interference did not significantly pre-
dict PCL-C scores, which suggests complete
mediation.
The indirect effect of pain catastrophizing
and pain anxiety combined with the relation-
ship between BPI-SF interference and PCL-C
scores was significant (indirect effect¼ 0.27;
99% bias-corrected CI¼ 0.0928e0.5108). An
examination of the individual indirect effects
of pain catastrophizing and pain anxiety
show that only pain anxiety is a mediator be-
cause the 99% bias-corrected CI did not con-
tain zero (CI¼ 0.1016e0.3441), meaning that
pain catastrophizing does contribute to the
overall indirect effect above and beyond pain
anxiety. Therefore, pain anxiety emerged as
the strongest mediator of the relationship
between BPI-SF interference and PCL-C
scores.Discussion
The aim of the present study was to examine
correlates of PTSD-related symptoms as deter-
mined by PCL-C scores in addition to the
relationship between pain interference and
PTSD-related symptoms in a sample of patients
receivingpalliative care. The results show that in
the hierarchical regression model used to iden-
tify statistical predictors of PCL-C scores, only
pain interference was significant. This finding
suggests that pain interference is more relevant
than pain anxiety to the transitional oncology
palliative care experience, when patients are
functionally declining from a stable palliative
care stage toward an end-of-life palliative care
stage, and pain intensity is mild and well
Table 2
Hierarchical Regression Model Predicting PCL-C Scores
Step Variable Total R2 R2 Change F-Change b
1 (n¼ 73) BPI-SF intensity 0.22 0.22 9.84 0.26a
BPI-SF interference 0.55b
2 (n¼ 73) BPI-SF intensity 0.22 0.00 0.31 0.27a
BPI-SF interference 0.54b
ESAS distress 0.06
3 (n¼ 73) BPI-SF intensity 0.43 0.21 5.85 0.20
BPI-SF interference 0.20
ESAS distress 0.06
PCS 0.04
PASS-20 0.39b
HADS-Anxiety 0.16
HADS-Depression 0.13
PCL-C¼ Post-Traumatic Stress Disorder ChecklistdCivilian version; BPI-SF¼ Brief Pain Inventory-Short Form; ESAS¼ Edmonton Symptom
Assessment System; PCS¼ Pain Catastrophizing Scale; PASS-20¼ Pain Anxiety Symptoms Scale-20; HADS¼Hospital Anxiety and Depression Scale.
aP< 0.05.
bP< 0.01.managed. This is consistent with the findings of
Asmundson et al.,52 which linked pain interfer-
ence to PTSD. It also relates to the suggestion
that daily awareness of pain interference may
act as a reminder of cancer-related trauma and
thus acts to maintain the relationship between
pain and PTSD-related symptoms in the transi-
tional oncology palliative care experience.29
Although previous research has not exam-
ined pain and psychosocial predictors of
PTSD-related symptoms in palliative care, pre-
vious studies suggest a significant comorbidity
of chronic pain and PTSD in other patient
populations.53e56 In the present study, pain
catastrophizing and pain anxiety were identi-
fied as individual mediators of the relationshipTable 3
Simple Mediator Models Assessing BPI-SF
Interference and PCL-C Scores
Model Step b t P
1dHADS-Anxiety 1 0.43 4.28 <0.01
2 0.37 3.66 <0.01
3 0.31 3.01 <0.01
4 0.31 3.04 <0.01
2dHADS-Depression 1 0.43 4.28 <0.01
2 0.43 4.29 <0.01
3 0.14 1.31 0.20
4 0.36 3.33 <0.01
3dPain catastrophizing 1 0.43 4.28 <0.01
2 0.62 7.11 <0.01
3 0.44 3.73 <0.01
4 0.16 1.33 0.19
4dPain anxiety 1 0.43 4.28 <0.01
2 0.58 6.45 <0.01
3 0.59 5.64 <0.01
4 0.09 0.83 0.41
BPI-SF¼ Brief Pain Inventory-Short Form; PCL-C¼ Post-Traumatic
Stress Disorder ChecklistdCivilian version; HADS¼Hospital Anx-
iety and Depression Scale.between pain interference and PTSD-related
symptoms, which provides support for these
previous findings.
However, neither HADS-A nor HADS-D
emerged as a significant mediator of the rela-
tionship between BPI-SF interference and
PCL-C scores, which is contrary to Sharp and
Harvey’s29 mutual maintenance model of pain
and PTSD. Pain anxiety emerged as the stron-
gest mediator of the relationship between BPI-
SF interference and PCL-C scores, above and
beyond the effect of pain catastrophizing;
thus, preoccupation with and worry over pain
may trigger PTSD-related symptoms in this co-
hort. Pain anxiety is conceptualized as fear of
pain, cognitive anxiety, escape/avoidance
behaviors, and physiological symptoms
of anxiety, all of which map onto Sharp and
Harvey’s29 mutual maintenance model. This
finding imparts clinical implications. First, clini-
cians should be aware of the co-occurrence of
pain interference and PTSD-related symptoms
in transitional oncology palliative care popula-
tions. Failure to assess the possibility of pain in-
terference may lead to the exacerbation of
symptomatology and increased distress for al-
ready vulnerable patients. Second, pain anxiety
and pain catastrophizing should be considered
as possible focal points of intervention in pa-
tients requiring palliative care. Previous re-
search has shown that cognitive-behavioral
therapy is an efficacious treatment for both
pain and PTSD-related symptoms, and may be
a valuable tool when working with this popula-
tion.42,57 Integrated treatment of pain and
Table 4
Multiple Mediator Model Assessing BPI-SF Interference and PCL-C Scores
Step Outcome Variable (Predictor Variable) b t P
1 PCL-C scores (BPI-SF interference) 0.43 4.28 <0.01
2 Pain catastrophizing (BPI-SF interference) 0.62 7.11 <0.01
Pain anxiety (BPI-SF interference) 0.58 6.45 <0.01
3 PCL-C scores (pain catastrophizing)a 0.16 1.25 0.22
PCL-C scores (pain anxiety)b 0.50 4.11 <0.01
4 PCL-C scores (BPI-SF interference)c 0.04 0.33 0.74
BPI-SF¼ Brief Pain Inventory-Short Form; PCL-C¼ Post-Traumatic Stress Disorder ChecklistdCivilian version.
aControlling for BPI-SF interference and pain anxiety.
bControlling for BPI-SF interference and pain catastrophizing.
cControlling for pain catastrophizing and pain anxiety.PTSD-related symptoms also has proven to be
beneficial.58
There are some limitations to the present
study. The cross-sectional study design does
not allow for the inference of causality, partic-
ularly related to the direction of the relation-
ships between variables. The relatively small
sample size also limits generalizability to
other populations. The convenience sampling
strategy of the present study may have intro-
duced bias into the data, and the fact that
only patients who were deemed well enough
to participate by health care professionals or
who could read and write English were in-
cluded in the study may have resulted in
some selection bias. The present study’s re-
sponse rate of 59.5% may have introduced
further bias into the study, particularly if signif-
icant differences existed between participants
and nonparticipants. Additionally, the MMSE
has not been widely accepted as a tool for de-
lirium screening because it is possible that in-
dividuals with a score higher than 24 could
potentially still fulfill the criteria for delirium.
The self-report ESAS scores were extracted
from hospital charts of inpatients one to two
days before the remainder of study data was
completed; therefore, the possibility exists
that the results of these measures were not ac-
curate at the time the other measures were col-
lected. Finally, age differences in the variables
of interest were not examined. Given the wide
age range of participants in the present study
(19e87 years), it is possible that differences
in the relationships between independent
and dependent variables may exist between
narrower age categories.
Notwithstanding these limitations, the find-
ings of the present study reveal that pain and
PTSD-related symptoms are important concerns
in palliative care. As the population of Canadacontinues to age and more Canadians are faced
with terminal illness and its associated pain and
psychological distress, the need for palliative
care services will increase. An important next
step would be to further examine the prevalence
and validity of PTSD and PTSD-related symptom
constructs in palliative care. Not surprisingly, the
findings of the present study also indicate that
transitional oncology palliative care patients
may experience their cancer diagnosis as a trau-
matic event; however, this requires replication
in further studies. Future research studies also
would benefit from including a clinically valid as-
sessment to establish a diagnosis of PTSD, which
would systematically address concerns about the
validity of PTSD in palliative care. Lastly, a longi-
tudinal study with a larger sample size may
broaden thegeneralizability of the study, provide
an opportunity to detect changes in pain and
PTSD-related symptomsover time, identify possi-
ble differences in the relationship between pain
and PTSD-related symptoms by age and sex, and
identify potential risk factors for PTSD-related
symptoms and PTSD. A better understanding
of the prevalence, interrelationship, andmutual
maintenance variables of pain and PTSD-related
symptoms may lend itself to improved assess-
ment strategies and treatment options for pa-
tients requiring palliative care.Disclosures and Acknowledgments
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